Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

110.18
Delayed Data
As of Jul 31
 +1.27 / +1.17%
Today’s Change
36.44
Today|||52-Week Range
138.85
-1.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Celgene Corp
Buy12/16/2014228,645$110.75$25.3M+2.52%
Higgons John Duncan
Chief Operating Officer
Sale7/16/201520,000$114.02$2.3M-4.43%
Biller Scott
Chief Scientific Officer
Sale9/19/201437,996$50.45$1.9M+125.27%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+72.80%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+72.80%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale2/09/201515,000$105.81$1.6M+3.98%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale7/17/201513,000$113.71$1.5M-3.95%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M+0.38%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M+0.38%
Higgons John Duncan
Chief Operating Officer
Sale12/01/201412,000$97.03$1.2M+14.45%
Page of 15